Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:59PM EDT. Market open.
| Previous close | 229.89 |
| Open | 233.61 |
| Bid | 234.00 x 900 |
| Ask | 234.44 x 1200 |
| Day's range | 233.04 - 238.38 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 533,343 |
| Market cap | 12.056B |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | 25.39 |
| EPS (TTM) | 9.22 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 270.80 |
ZacksSotera Health Company (SHC) Misses Q1 Earnings and Revenue Estimates
Sotera Health (SHC) delivered earnings and revenue surprises of -7.14% and 2.57%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
WILMINGTON, Mass., May 02, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV) portfolio, designed to streamline Cell and Gene Therapy (CGT) research and development as it scales to Good Manufacturing Practice- (GMP) quality.
ZacksICLR vs. CRL: Which Stock Is the Better Value Option?
ICLR vs. CRL: Which Stock Is the Better Value Option?
© 2024 Yahoo. All rights reserved.